Advertisement

Superoxide dismutase and catalase activities and their correlation with malondialdehyde in schizophrenic patients

  • Rukmini M. S. 
  • Benedicta D'Souza
  • Vivian D'Souza
Article

Abstract

Free radical mediated pathological processes may have a role in schizophrenia. Free radicals (oxy radicals, such as superoxide, hydroxyl ions and nitric oxide) cause cell injury, when they are generated in excess or when the antioxidant defense is impaired. Both these processes seem to be affected in schizophrenia. In this study we investigated erythrocyte superoxide dismutase (SOD) and catalase (CAT) activities as antioxidant enzymes, malondialdehyde (MDA) as a sign of lipid peroxidation in schizophrenic patients. Activities of superoxide dismutase, catalase and malondialdehyde were greater in patients compared with the control group which may reflect increased oxidative stress in the brain tissue of schizophrenics. In the patient group erythrocyte SOD and CAT activities were weakly negative correlated with MDA concentration. These data reveal that antioxidant defense mechanisms might be impaired in schizophrenic patients. These findings also provide a theoretical basis for the development of novel therapeutic strategies, such as antioxidant supplementation.

Key Words

Lipid peroxidation Superoxide dismutase Catalase Schizophrenia 

References

  1. 1.
    Halliwell, B. (1992) Reactive oxygen species and the central nervous system. J. Neurochem. 59, 1609–1623.PubMedCrossRefGoogle Scholar
  2. 2.
    Lohr, J.B. (1991) Oxygen radicals and neuropsychiatric illness: some speculations. Arch. Gen. Psychiatr. 48, 1097–1106.PubMedGoogle Scholar
  3. 3.
    Reddy, R.D. and Yao, J.K. (1996) Free radical pathology in schizophrenia. Prostaglandins Leukot. Essent. Fatty acids 55 (1–2), 33–43.PubMedCrossRefGoogle Scholar
  4. 4.
    Cadet, J.L. and Kahler, L.A. (1994) Free radical mechanisms in schizophrenia and tardive dyskynesia. Neuro. Sci. Biobehav. Res. 18 (4), 457–467.CrossRefGoogle Scholar
  5. 5.
    Dusica, P. and Vesna, T. (2002) Oxidative stress as marker of positive symptoms in schizophrenia. Facta Universitatis. Medicine & Biology. 9 (2), 157–161.Google Scholar
  6. 6.
    Mahadik, S.P. and Scheffer, R.E. (1996) Oxidative injury and potential use of antioxidants in schizophrenia. Prostag. Leuko. Ess. 55, 45–54.CrossRefGoogle Scholar
  7. 7.
    Satoh, K. (1978) Serum lipid peroxide in cerebrovascular disorders determined by new colorimetric method. Clin. Chem. Acta 90, 37–43.CrossRefGoogle Scholar
  8. 8.
    Wasowicz, W., Neve, J and Peretz, A. (1993) Optimised Steps in Flourimetric Determination of Thiobarbituric Acid reactive substances in serum: Importance of extraction pH and influence of sample preservation and storage. Clin. Chem. 39 (12), 2522–2526.PubMedGoogle Scholar
  9. 9.
    Stocks, J. and Dormondy, T.L. (1971) The auto oxidation of human red cell lipids induced by hydrogen peroxide. Br. J. Haematol. 20, 95–111.PubMedCrossRefGoogle Scholar
  10. 10.
    Mc Cord and Fridovich, I. (1969) Superoxide dismutase on enzymatic function for erythrocumein. J. Biol. Chem. 24, 6049–6055.Google Scholar
  11. 11.
    Beauchamp, C. and Fridovich, I. (1971) Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels. Anal. Biochem. Review. 44, 276–287.CrossRefGoogle Scholar
  12. 12.
    Sun, Y., Oberley, L.W. and Li, Y. (1988) A simple method for clinical assay of superoxide dismutase. Clin. Chem. 34, 497–500.PubMedGoogle Scholar
  13. 13.
    Brannan, T.S., Maker, H.O. and Raess, I.P. (1981) Regional distribution of catalase in adult rat brain. J. Neurochem. 86, 307–309.CrossRefGoogle Scholar
  14. 14.
    Sinet, P.M., Heikkila, R.E. and Cohen, G. (1980) Hydrogen peroxide production from rat brain in vivo. J. Neurochem. 34, 1421–1428.PubMedCrossRefGoogle Scholar
  15. 15.
    Drabkin, D.L. et al. (1932). J. Biochem. 98, 719.Google Scholar
  16. 16.
    Nikushkin, E.V., Kryzhanovski, G.N., Tupeer, I.R., Bordyukov, M.M. and Yuzefova, S.M. (1987). Blood antioxidant enzymes during epileptic activity. Bull. Ekesp. Biol. Med. 3, 297–299.Google Scholar
  17. 17.
    Smith, C.D., Carney, J.M., Sturke Reed, P.E., Oliver, C.N., Stadman, E.R., Floyd, R.A. and Markesbery, W.R. (1991) Excess brain protein oxidation and enzymes dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 88, 10540–10543.PubMedCrossRefGoogle Scholar
  18. 18.
    Abdulla, D.S.P., Monteiro, I.I.P., Oliveira, J.A.C. and Bechara, E.J.H. (1986) Activities of Superoxide dismutase and glutathione peroxidase in Schizophrenic and manic depressive patients. Clin. Chem. 32 (5), 805–807.Google Scholar
  19. 19.
    Halliwell, B. (1989) Oxidants and central nervous system. Some fundamental questions. Acta. Neurol. Scand. 126, 23–33.Google Scholar
  20. 20.
    Glenberg, A.J., Bassuk, E.L. and Schoonover, S. (1991) The practitioner's guide to Psycho active drugs. New York Plenum Publishing Co. 143.Google Scholar
  21. 21.
    Reddy, R., Mahadik, P.S., Sukdeb, M. and Jayasimha, N.M. (1991) Enzymes of the Antioxidant Defense System in Chronic Schizophrenic Patients. Biol. Psychiatry. 30, 409–412.PubMedCrossRefGoogle Scholar
  22. 22.
    Yao, J.K., Ravinder, D.R. and Daniel, P. van Kammen. (1999) Human Plasma Glutathione Peroxidase and Symptom Severity in Schizophrenia. Biol. Psychiatry. 45, 1512–1515.PubMedCrossRefGoogle Scholar
  23. 23.
    Janero, D.R. (1990) Malondialdehyde and thiobarbituric acid reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free radical Bio. Med. 9, 515–540.CrossRefGoogle Scholar
  24. 24.
    Pall, H.S., Williams, A.C., Blake, D.R. and Lunec, J. (1987) Evidence of enhanced lipid peroxidation in cerebrospinal fluid of patients taking phenothiazines. Lancet. 72, 535–539.Google Scholar
  25. 25.
    Mc. Credie, R.G., Mac Donald, E., Wiles, D., Campbell, G. and Peterson, J.R. (1995) The Nithsdale Schizophrenia Survey. XIV: Plasma lipid peroxide and serum Vitamin E levels in patients with and without tardive dyskinesia and in normal subjects. Br. J. Psychiatry 167, 610–617.CrossRefGoogle Scholar
  26. 26.
    Benedicta, D. and Vivian, D. (2003) Oxidative injury and antioxidant vitamins E and C in Schizophrenia. Ind. J. of Clin. Biochem. 18 (1), 87–90.CrossRefGoogle Scholar
  27. 27.
    Strunecka, A. and Ripova, D. (1999) What can the investigation of phosphoinositide signaling system in platelets of schizophrenic patients tell us? Prostaglandins Leukot Essent Fatty Acids. 61 (1), 1–5.PubMedCrossRefGoogle Scholar
  28. 28.
    Heales, S.J.R., Barker, J.E., Stewart, V.C., Brand, M.P., Hargreaves, I.P., Land, J.M., Clark, J.B. and Bolanos, J.P. (1997) Nitric oxide energy metabolism and neurological disease. Biochem. Soc. Trans. 25 (3), 939–943.PubMedGoogle Scholar

Copyright information

© Association of Clinical Biochemists of India 2004

Authors and Affiliations

  • Rukmini M. S. 
    • 1
  • Benedicta D'Souza
    • 1
  • Vivian D'Souza
    • 1
  1. 1.Department of Biochemistry, Centre for Basic SciencesKasturba Medical CollegeMangaloreIndia

Personalised recommendations